Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT)
NCT00475098
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
553
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Non Small Cell Lung Cancer
Interventions
DRUG:
Tinzaparin sodium 100 UI/Kg/OD for 12 weeks
Sponsor
Assistance Publique - Hôpitaux de Paris